Offer - Urjas Oil for just ₹ 1 X
Ropiro 0.25 Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Parkinson's Disease, Restless Legs Syndrome. The alternative uses of Ropiro 0.25 Tablet have also been explained below.
The correct dosage of Ropiro 0.25 Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The most common side effects of Ropiro 0.25 Tablet are Sleepiness, Weakness, Influenza like symptoms. Some other side effects of Ropiro 0.25 Tablet have been listed ahead. Such side effects of Ropiro 0.25 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Ropiro 0.25 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. In addition, Ropiro 0.25 Tablet's effects on the liver, heart and kidney are discussed below in the Ropiro 0.25 Tablet related warnings section.
Ropiro 0.25 Tablet is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Psychosis as it can result in adverse effects. Some other conditions that can be affected by Ropiro 0.25 Tablet are listed in the contraindications section below.
Drug reaction of Ropiro 0.25 Tablet with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Ropiro 0.25 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Ropiro 0.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Ropiro 0.25 Tablet safe for pregnant women?
Ropiro may have some side effects during pregnancy. Pregnant women should discontinue the use of Ropiro, and talk to their doctor, if they notice any discomfort.
Is the use of Ropiro 0.25 Tablet safe during breastfeeding?
Ropiro should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Ropiro 0.25 Tablet on the Kidneys?
Ropiro may have mild side effects on the kidneys.
What is the effect of Ropiro 0.25 Tablet on the Liver?
Ropiro is rarely harmful for the liver.
What is the effect of Ropiro 0.25 Tablet on the Heart?
Ropiro is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Ropiro 0.25 Tablet unless your doctor advises you to do so -
Is this Ropiro 0.25 Tablet habit forming or addictive?
Ropiro 0.25 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Ropiro 0.25 Tablet can make you feel drowsy.
Is it safe?
Yes, but take Ropiro 0.25 Tablet only as per medical advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Ropiro 0.25 Tablet can help with mental disorders.
Interaction between Food and Ropiro 0.25 Tablet
Taking Ropiro 0.25 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Ropiro 0.25 Tablet
Consuming Ropiro 0.25 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Requip (ropinirole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1114-1116